AGP Executive Report
Last update: 10 hours agoHealthcare Deals: McKesson and private-equity firm CD&R agreed to acquire home-infusion provider Option Care Health for about $5.8 billion, while Genentech licensed Alector’s Parkinson’s drug program in a deal worth up to $1.27 billion. Pharma Investment: Bayer plans a $2.2 billion manufacturing campus in Ohio, adding to a wave of investment in drug production. Medicare Innovation: Walmart and SCAN will launch co-branded Medicare Advantage plans in parts of Texas and Arizona in 2027, combining senior-focused coverage with personalized health support. Employer Costs: The Health Transformation Alliance and State Financial Officers Foundation introduced a scorecard to help employers use healthcare pricing data to scrutinize spending. Vaccine Research: An AI-assisted approach helped mRNA vaccines remain stable at room temperature for up to a year in early research, potentially easing cold-storage barriers if the findings translate beyond animal studies.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[FDA Clears IDE for NeuWire Medical's STROKE-REWIRE Trial in Chronic Ischemic Stroke]]>](https://cdn.sanity.io/images/0vv8moc6/patientcare/86ae466140c2bffe2138b62607ae471c8ad04ef7-1200x628.jpg)
